Power Corporation of Canada
F:PCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Power Corporation of Canada
F:PCR
|
CA |
|
F
|
Fortress Biotech Inc
F:CNB
|
US |
|
Canfor Corp
TSX:CFP
|
CA |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
F:ME9
|
IT |
|
C
|
Colliers International Group Inc
F:FSV
|
CA |
|
N
|
New Silkroad Culturaltainment Ltd
XBER:CP2
|
HK |
Wall St Price Targets
PCR Price Targets Summary
Power Corporation of Canada
According to Wall Street analysts, the average 1-year price target for PCR is 39.18 EUR with a low forecast of 33.72 EUR and a high forecast of 43.22 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCR's stock price target?
Price Target
39.18
EUR
According to Wall Street analysts, the average 1-year price target for PCR is 39.18 EUR with a low forecast of 33.72 EUR and a high forecast of 43.22 EUR.
What is the Revenue forecast for Power Corporation of Canada?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Power Corporation of Canada?
Projected CAGR
28%
Over the last 14 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 2 years is 28%.
